CDKN2B and atherosclerosis: Considering that CDKN2B-AS1 was downregulated and ADAM10 was highly expressed in patients with atherosclerosis, the following experiments were conducted to investigate the mechanism by which CDKN2B-AS1 could inhibit ADAM10 expression.